Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Simcere Pharmaceutical Group Limited (HK:2096)
HKEX:2096
Simcere Pharmaceutical Group Limited (2096) Stock Price & Analysis
2 Followers
2096 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$4.79 - HK$7.81
Previous CloseHK$5.67
Volume1.75M
Average Volume (3M)4.92M
Market Cap
HK$14.42B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)18.7
Beta0.60
Next Earnings
Mar 31, 2023EPS EstimateN/A
Last Dividend Ex-Date
Jun 18, 2024Dividend Yield3.08%
Share Statistics
EPS (TTM)0.34
Shares Outstanding2,609,761,618
10 Day Avg. Volume2,435,000
30 Day Avg. Volume4,918,556
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$8.20Price Target Upside44.62% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Simcere Pharmaceutical Group Limited News
PremiumCompany Announcements
Simcere’s COVID-19 Drug Wins Regular Approval in China
PremiumCompany Announcements
Simcere’s ENLITUO Approved for Cancer Therapy in China
PremiumCompany Announcements
Simcere Pharmaceutical Implements Share Buyback Plan
PremiumCompany Announcements
Simcere Pharmaceutical Announces Secretary Change
PremiumCompany Announcements
Simcere Pharmaceutical Declares Final DividendPremiumCompany Announcements
Simcere Pharmaceutical Announces AGM Decisions
PremiumCompany Announcements
Simcere’s ENZESHU Shows Promise in Ovarian Cancer TrialPremiumCompany Announcements
Simcere’s Sleep Drug Triumphs in Phase III TrialOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.90% Mutual Funds
1.34% Other Institutional Investors
97.76% Public Companies and
Individual Investors
2096 FAQ
What was Simcere Pharmaceutical Group Limited’s price range in the past 12 months?
Simcere Pharmaceutical Group Limited lowest stock price was HK$4.79 and its highest was HK$7.81 in the past 12 months.
What is Simcere Pharmaceutical Group Limited’s market cap?
Currently, no data Available
When is Simcere Pharmaceutical Group Limited’s upcoming earnings report date?
Simcere Pharmaceutical Group Limited’s upcoming earnings report date is Mar 31, 2023 which is 474 days ago.
How were Simcere Pharmaceutical Group Limited’s earnings last quarter?
Simcere Pharmaceutical Group Limited released its earnings results on Aug 31, 2022. The company reported HK$0.022 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.022.
Is Simcere Pharmaceutical Group Limited overvalued?
According to Wall Street analysts Simcere Pharmaceutical Group Limited’s price is currently Undervalued.
Does Simcere Pharmaceutical Group Limited pay dividends?
Simcere Pharmaceutical Group Limited pays a Annually dividend of HK$0.17 which represents an annual dividend yield of 3.08%. See more information on Simcere Pharmaceutical Group Limited dividends here
What is Simcere Pharmaceutical Group Limited’s EPS estimate?
Simcere Pharmaceutical Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Simcere Pharmaceutical Group Limited have?
Simcere Pharmaceutical Group Limited has 2,543,785,600 shares outstanding.
What happened to Simcere Pharmaceutical Group Limited’s price movement after its last earnings report?
Simcere Pharmaceutical Group Limited reported an EPS of HK$0.022 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.644%.
Which hedge fund is a major shareholder of Simcere Pharmaceutical Group Limited?
Currently, no hedge funds are holding shares in HK:2096
---
Simcere Pharmaceutical Group Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.92%
12-Months-Change
Fundamentals
Return on Equity
11.12%
Trailing 12-Months
Asset Growth
-1.28%
Trailing 12-Months
Company Description
Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Ltd is engaged in the R&D, production and commercialization of pharmaceuticals focused on generic pharmaceuticals. It has a diversified product portfolio focused on therapeutic areas, including, oncology (including cell therapy), nervous system diseases, autoimmune diseases and antiinfection. The company's products include Endostar, Enweida, Iremod, Sanbexin and Others.
---
2096 Stock 12 Month Forecast
Average Price Target
HK$8.20
▲(44.62% Upside)
Technical Analysis
Top Spring International Holdings Limited
―
Alibaba Group Holding Ltd.
―
Kaisa Prosperity Holdings Ltd.
―
Best Analysts Covering 2096
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+6.40%
reiterated a buy rating 4 months ago
Copying Sean Wu CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +6.40% per trade.
---